Blood Tests May be the Future for Early Alzheimer’s Detection
source: shutterstock.com

Blood Tests May be the Future for Early Alzheimer’s Detection

It is estimated that over six million people in the U.S. have Alzheimer’s disease plus millions of other people throughout the world. Alzheimer’s is the most common type of dementia.…

Continue Reading Blood Tests May be the Future for Early Alzheimer’s Detection
Does Brain Inflammation Play a Role in Alzheimer’s Disease?
source: shutterstock.com

Does Brain Inflammation Play a Role in Alzheimer’s Disease?

Neurogeneticist Michael Nalls of the US National Institute on Aging recently told Science Alert that a 2022 study, published in the Journal of Alzheimer’s Disease, completely changed their discovery approach.…

Continue Reading Does Brain Inflammation Play a Role in Alzheimer’s Disease?
Alzheimer’s: A Neuroscientist at the OHSU Claims Scientists Missed a Major Form of Cell Death
source: pixabay.com

Alzheimer’s: A Neuroscientist at the OHSU Claims Scientists Missed a Major Form of Cell Death

Ferroptosis, a form of cell death, destroys microglia cells, which are associated with the brain’s immune system in vascular dementia and Alzheimer’s. Dr. Stephen Back suggested that attention had not…

Continue Reading Alzheimer’s: A Neuroscientist at the OHSU Claims Scientists Missed a Major Form of Cell Death
Alzheimer’s: Another Drug Failure Has the Researchers Questioning the Science
source: shutterstock.com

Alzheimer’s: Another Drug Failure Has the Researchers Questioning the Science

  Roche has added another failure this year with its drug gantenerumab. As noted in Fierce Biotech, the drug was unable to improve functional or cognitive decline in two Phase…

Continue Reading Alzheimer’s: Another Drug Failure Has the Researchers Questioning the Science
November was Alzheimer’s Awareness Month
source: pixabay.com

November was Alzheimer’s Awareness Month

  The need for increased awareness about Alzheimer’s disease is growing. The number of Alzheimer’s patients has increased since 1983, the year President Reagan designated November as Alzheimer’s Disease Awareness…

Continue Reading November was Alzheimer’s Awareness Month
New Podcast Episode: Going All In On Support, feat. Patient Advocates Kathi and Dave Herzog
source: shutterstock.com

New Podcast Episode: Going All In On Support, feat. Patient Advocates Kathi and Dave Herzog

We are excited to announce that Patient Worthy's award-winning podcast "Wait, How Do You Spell That? A Rare Disease Podcast" is back with a new episode. This week, Colby is…

Continue Reading New Podcast Episode: Going All In On Support, feat. Patient Advocates Kathi and Dave Herzog
Scientists Demonstrate Gut Microbiome Connection with Transfer of Alzheimer’s to Healthy Animals
source: pixabay.com

Scientists Demonstrate Gut Microbiome Connection with Transfer of Alzheimer’s to Healthy Animals

  Scientists have previously suggested that the gut microbiome plays a role in causing Alzheimer’s disease, and this has now been confirmed. A recent report from ScienceAlert covered a study…

Continue Reading Scientists Demonstrate Gut Microbiome Connection with Transfer of Alzheimer’s to Healthy Animals
AI Can Predict Dementia Fifteen Years Prior to Symptoms Occurring
source: pixabay.com

AI Can Predict Dementia Fifteen Years Prior to Symptoms Occurring

Editor's Note: We believe that patients are a key part of developing and leading the conversation in disease communities. Patient Worthy sometimes partners with reputable agencies that wish to speak…

Continue Reading AI Can Predict Dementia Fifteen Years Prior to Symptoms Occurring
FDA Panel Backs Approval of a New Drug for Alzheimer’s
source: pixabay.com

FDA Panel Backs Approval of a New Drug for Alzheimer’s

  The FDA advisory panel which is composed of specialists who advise the FDA on brain medications, recently voted 6-0 in agreement on that the new drug, Leqembi, was effective…

Continue Reading FDA Panel Backs Approval of a New Drug for Alzheimer’s
Alzheimer’s Disease: An Influential 2006 Study Containing False Images Leads Scientists To Reverse Previous Theories
source: pixabay.com

Alzheimer’s Disease: An Influential 2006 Study Containing False Images Leads Scientists To Reverse Previous Theories

  The failure rate of drug development for Alzheimer’s is 99 percent according to a recent study. Since 1984 scientists have concentrated on developing treatments to prevent the formation of…

Continue Reading Alzheimer’s Disease: An Influential 2006 Study Containing False Images Leads Scientists To Reverse Previous Theories
Study of the Week: A Device That Can Detect Alzheimer’s 17 Years Before Symptoms Start
source: pixabay.com

Study of the Week: A Device That Can Detect Alzheimer’s 17 Years Before Symptoms Start

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

Continue Reading Study of the Week: A Device That Can Detect Alzheimer’s 17 Years Before Symptoms Start

Editor’s Choice: A Biomarker for Early Alzheimer’s Detection, A Teen Living with Usher Syndrome, and A Possible Chagas Disease Treatment

Happy Monday! This week, we have details on a method for detecting Alzheimer's 17 years in advance, the story of a teen living with Usher syndrome, and a possible breakthrough…

Continue Reading Editor’s Choice: A Biomarker for Early Alzheimer’s Detection, A Teen Living with Usher Syndrome, and A Possible Chagas Disease Treatment
Alzheimer’s Disease: Study Suggests a Connection Between Digestive Disorders and AD
source: pixabay.com

Alzheimer’s Disease: Study Suggests a Connection Between Digestive Disorders and AD

  The gut-brain axis has recently been mentioned in connection with various disorders. According to an article in SciTechDaily, a study at ECU’s Centre for Precision Health confirms a genetic…

Continue Reading Alzheimer’s Disease: Study Suggests a Connection Between Digestive Disorders and AD

Alzheimer’s: German and UK Scientists Successfully Reduced Alzheimer’s Symptoms in Laboratory Animals

  Eureka Alert recently published a statement by a team of researchers that early results of a new method of treating Alzheimer’s have been “absolutely spectacular.” The new antibody-based therapy…

Continue Reading Alzheimer’s: German and UK Scientists Successfully Reduced Alzheimer’s Symptoms in Laboratory Animals
Alzheimer’s: A 50-year-old FDA Approved Diuretic Restored Normal Brain Activity in Mice; Will It Work On Humans?
source: pixabay.com

Alzheimer’s: A 50-year-old FDA Approved Diuretic Restored Normal Brain Activity in Mice; Will It Work On Humans?

  When you are looking for new treatments that will either stop or slow the development of Alzheimer’s disease, where would you look? According to a recent article in Gladstone…

Continue Reading Alzheimer’s: A 50-year-old FDA Approved Diuretic Restored Normal Brain Activity in Mice; Will It Work On Humans?
 Scientists Announce Breakthrough Discovery for Alzheimer’s and Other Neurological Diseases
source: pixabay.com

 Scientists Announce Breakthrough Discovery for Alzheimer’s and Other Neurological Diseases

   The Times Now News recently featured an article that highlighted a study by a group of NYU Langone scientists. The study paper was published October 6th, 2021 in the…

Continue Reading  Scientists Announce Breakthrough Discovery for Alzheimer’s and Other Neurological Diseases
Biogen’s Newly Approved Alzheimer’s Drug Ships in 2 Weeks. The Confirmatory Trial Will Take 8 Years.
source: pixabay.com

Biogen’s Newly Approved Alzheimer’s Drug Ships in 2 Weeks. The Confirmatory Trial Will Take 8 Years.

  The pressure was on. Researchers had been studying Alzheimer’s for decades. Every morsel of discovery was hailed as moving closer to a cure and results were always expected soon…

Continue Reading Biogen’s Newly Approved Alzheimer’s Drug Ships in 2 Weeks. The Confirmatory Trial Will Take 8 Years.
FDA Approves New Alzheimer’s Drug, But Not Without Controversy
source: pixabay.com

FDA Approves New Alzheimer’s Drug, But Not Without Controversy

According to an announcement from the US Food and Drug Administration (FDA), the agency has recently approved a new therapy for Alzheimer's disease. While this is a significant moment for…

Continue Reading FDA Approves New Alzheimer’s Drug, But Not Without Controversy
Study of the Week: Primary Progressive Aphasia Patients with Alzheimer’s Keep Their Memory
source: pixabay.com

Study of the Week: Primary Progressive Aphasia Patients with Alzheimer’s Keep Their Memory

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

Continue Reading Study of the Week: Primary Progressive Aphasia Patients with Alzheimer’s Keep Their Memory
Discovery of Three Molecular Subtypes Brings Us Closer to Unraveling Alzheimer’s Disease
source: pixabay.com

Discovery of Three Molecular Subtypes Brings Us Closer to Unraveling Alzheimer’s Disease

  There are many common elements in Alzheimer’s disease (AD), which is the most common type of dementia. It is now evident that there are varied spans of disease progression…

Continue Reading Discovery of Three Molecular Subtypes Brings Us Closer to Unraveling Alzheimer’s Disease
Baylor College Team Discovers the Origin of Alpha-1 Antitrypsin Deficiency in Infants
source: pixabay.com

Baylor College Team Discovers the Origin of Alpha-1 Antitrypsin Deficiency in Infants

  A recent article in Science News highlighted a discovery by Richard Seifes, M.D. of Baylor College of Medicine.  Dr. Seifes has discovered the origin of a liver disease that…

Continue Reading Baylor College Team Discovers the Origin of Alpha-1 Antitrypsin Deficiency in Infants
Patients Receive First Dosing of Experimental Drug Targeting Neurodegenerative Diseases
source: pixabay.com

Patients Receive First Dosing of Experimental Drug Targeting Neurodegenerative Diseases

  According to a recent article in Business Wire, it is estimated that five million people in the United States over the age of sixty-five are coping with Alzheimer’s at…

Continue Reading Patients Receive First Dosing of Experimental Drug Targeting Neurodegenerative Diseases